Abstract
The differential diagnosis of primary hypersomnias in women includes narcolepsy (type 1/with cataplexy and type 2/without cataplexy), idiopathic hypersomnia, recurrent hypersomnia (Klein-Levin Syndrome, menstrual-related hypersomnia), idiopathic hypersomnia, behaviorally induced insufficient sleep syndrome, hypersomnia due to a medical disorder, hypersomnia due to a medication or substance, and hypersomnia associated with a psychiatric disorder. The hallmark symptom of hypersomnia is excessive daytime sleepiness (EDS). There is evidence suggesting higher prevalence of EDS in women, possibly due to work and family responsibilities, increased prevalence of mood disorders, hormonal changes, and/or the underdiagnoses of sleep disorders in women. In the realm of recurrent hypersomnias, menstrual-related hypersomnia is especially of importance in the evaluation of women. Similarly, given the increased prevalence of depression in women, the relationship between hypersomnia and depression is important to be aware of in evaluating these patients as well. There are several different options for treatment of primary hypersomnias. Special consideration should be given when prescribing modafinil or armodafinil to women given the interaction of these medications with exogenous hormones and oral contraceptives, leading to reduced efficacy and increased clearance of these hormonal treatments. Not enough pregnancy safety data exists with any of the pharmacological treatments for hypersomnia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dauvilliers Y, Barateau L. Narcolepsy and other central hypersomnias. Continuum (Minneap Minn). 2017;23(4):989–1004.
Chasens ER, Twerski SR, Yang K, Umlauf MG. Sleepiness and health in midlife women: results of the National Sleep Foundation’s 2007 sleep in America poll. Behav Sleep Med. 2010;8(3):157–71.
Liu X, Uchiyama M, Kim K, et al. Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res. 2000;93(1):1–11.
Doi Y, Minowa M. Gender differences in excessive daytime sleepiness among Japanese workers. Soc Sci Med. 2003;56(4):883–94.
Theorell-Haglow J, Lindberg E, Janson C. What are the important risk factors for daytime sleepiness and fatigue in women? Sleep. 2006;29(6):751–7.
Lichstein KL, Durrence HH, Riedel BW, Taylor DJ, Bush AJ. Epidemiology of sleep. (3 should actually be 7). Mahwah: Lawrence Erlbaum Associates; 2004.
Pagel JF. Excessive daytime sleepiness. Am Fam Physician. 2009;79(5):391–6.
Baldwin CM, Kapur VK, Holberg CJ, Rosen C, Nieto FJ. Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study. Sleep. 2004;27(2):305–11.
Beaudreau SA, Spira AP, Stewart A, et al. Validation of the Pittsburgh sleep quality index and the Epworth sleepiness scale in older black and white women. Sleep Med. 2011;13(1):36–42.
Liu X, Sun Z, Uchiyama M, Shibui K, Kim K, Okawa M. Prevalence and correlates of sleep problems in Chinese schoolchildren. Sleep. 2000;23(8):1053–62.
Lamarche LJ, Driver HS, Wiebe S, Crawford L, DE Koninck JM. Nocturnal sleep, daytime sleepiness, and napping among women with significant emotional/behavioral premenstrual symptoms. J Sleep Res. 2007;16(3):262–8.
Baker FC, Colrain IM. Daytime sleepiness, psychomotor performance, waking EEG spectra and evoked potentials in women with severe premenstrual syndrome. J Sleep Res. 2010;19(1 Pt 2):214–27.
Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol. 1997;103(5):554–62.
Mitler MM, Doghramji K, Shapiro C. The maintenance of wakefulness test: normative data by age. J Psychosom Res. 2000;49(5):363–5.
American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005.
Rye DB, Dihenia B, Weissman JD, Epstein CM, Bliwise DL. Presentation of narcolepsy after 40. Neurology. 1998;50(2):459–65.
Wise MS. Childhood narcolepsy. Neurology. 1998;50(2 Suppl 1):S37–42.
Black JE, Brooks SN, Nishino S. Narcolepsy and syndromes of primary excessive daytime somnolence. Semin Neurol. 2004;24(3):271–82.
Wieczorek S, Gencik M, Rujescu D, et al. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens. 2003;61(6):437–42.
Kato T, Honda M, Kuwata S, et al. Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: no association with narcolepsy. Am J Med Genet. 1999;88(4):301–4.
Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–85.
Kanbayashi T, Inoue Y, Chiba S, et al. SF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res. 2002;11(1):91–3.
Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27(3):469–74.
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40.
Khatami R, Maret S, Werth E, et al. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet. 2004;363(9416):1199–200.
Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep. 2009;32(8):993–8.
Scammell TE. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep. 2006;29(5):601–2.
Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep. 2006;29(5):633–8.
Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705–11.
Lernmark Å. Environmental factors in the etiology of type 1 diabetes, celiac disease, and Narcolepsy. Pediatr Diabetes. 2016;17:65–72.
Krystal A, Attarian H. Sleep medications and women: a review of issues to consider for optimizing the care of women with sleep disorders. Curr Sleep Med Rep. 2016;2(4):218–22.
U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004;5(2):119–23.
Calik MW. Update on the treatment of Narcolepsy: clinical efficacy of Pitolisant. Nat Sci Sleep. 2017;9:127–33.
Thorpy MJ, Shapiro C, Mayer G. A randomized study of Solriamfetol for excessive sleepiness in Narcolepsy. Ann Neurol. 2019;85(3):359–70.
AlShareef SM, Smith RM, BaHammam AS. Kleine-Levin syndrome: clues to aetiology. Sleep Breath. 2018;22(3):613–23.
Katz JD, Ropper AH. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol. 2002;59(12):1959–61.
Janicki S, Franco K, Zarko R. A case report of Kleine-Levin syndrome in an adolescent girl. Psychosomatics. 2001;42(4):350–2.
Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59(11):1739–45.
BaHammam AS, GadElRab MO, Owais SM, Alswat K, Hamam KD. Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med. 2008;9(5):575–8.
Billiard M, Guilleminault C, Dement WC. A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Neurology. 1975;25(5):436–43.
Papy JJ, Conte-Devolx B, Sormani J, Porto R, Guillaume V. The periodic hypersomnia and megaphagia syndrome in a young female, correlated with menstrual cycle (author’s transl). Rev Electroencephalogr Neurophysiol Clin. 1982;12(1):54–61.
Sachs C, Persson HE, Hagenfeldt K. Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology. 1982;32(12):1376–9.
Bamford CR. Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep. 1993;16(5):484–6.
Manber R, Bootzin RR. Sleep and the menstrual cycle. Health Psychol. 1997;16(3):209–14.
Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and Management of Patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918–28.
Huang YS, Lakkis C, Guilleminault C. Kleine-Levin syndrome: current status. Med Clin North Am. 2010;94(3):557–62.
de Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev. 2016;5:CD006685.
Dauvilliers Y, Evangelista E, Lopez R, et al. Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders. Ann Neurol. 2016;80(2):259–68.
Lavault S, Dauvilliers Y, Drouot X, et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med. 2011;12(6):550–6.
Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time – a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74–81.
Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12(3):331–44.
Trotti LM, Saini P, Freeman AA, et al. Patients improvement in daytime sleepiness with clarithromycin in with GABA-related hypersomnia: clinical experience. J Psychopharmacol. 2014;28(7):697–702.
Trotti LM, Saini P, Koola C, LaBarbera V, Bliwise DL, Rye DB. Flumazenil for the treatment of refractory Hypersomnolence: clinical experience with 153 patients. J Clin Sleep Med. 2016;12(10):1389–94.
Voelker R. Women and depression. JAMA. 2001;285(11):1432.
Vgontzas AN, Bixler EO, Kales A, Criley C, Vela-Bueno A. Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med. 2000;62(2):220–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Reid, R.U., Attarian, H. (2020). Central Hypersomnias in Adult Women of Childbearing Age. In: Attarian, H., Viola-Saltzman, M. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-030-40842-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-40842-8_15
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-40841-1
Online ISBN: 978-3-030-40842-8
eBook Packages: MedicineMedicine (R0)